Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opko Health Inc (OPK)
NASDAQ:OPK
OPK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.86 - $1.76
Previous CloseN/A
Volume574.71K
Average Volume (3M)2.79M
Market Cap
$1.12B
Enterprise Value$1.59B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Feb 27, 2025EPS Estimate
-0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding682,483,030
10 Day Avg. Volume3,312,287
30 Day Avg. Volume2,787,645
Standard Deviation0.21
R-Squared0.17
Alpha0.00088
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.57
Price to Cash Flow (P/CF)2.00
P/FCF Ratio2.10
Enterprise Value/Market Cap1.42
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.01
Enterprise Value/Ebitda84.08
Forecast
1Y Price Target
$3.00Price Target Upside74.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Opko Health News
PremiumCompany Announcements
OPKO Health to Announce Q4 2024 Financial Results
PremiumCompany Announcements
Opko Health Engages Investors at J.P. Morgan Conference
PremiumCompany Announcements
OPKO Health Shows Strategic Progress in Q3 2024
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceNet income was $24.9M, or $0.03 per diluted share, beating our estimated loss of $66.5M due to $121.5M of gain on sale of assets.
Financial StrategyOPKO is utilizing its newfound financial strength to repurchase common shares and convertible notes, indicating confidence in its financial position.
Vaccine DevelopmentThe Phase 1 trial of an Epstein-Barr virus (EBV) vaccine candidate has dosed the first participant, triggering a cash milestone payment from Merck.
Bears Say
Earnings PerformanceOPKO’s third quarter top-line performance was a bit light relative to expectations, with revenue coming in lower than estimated.
Profitability ExpectationsThe company’s assumption for segment profitability in FY/25 does not include any heroic levels of top-line growth.
Revenue DeclineConsolidated total revenues were $173.6M, representing 3% YoY decline and missing our projection of $181M.
---
Ownership Overview
51.37% Insiders
6.38% Mutual Funds
9.25% Other Institutional Investors
21.45% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPK FAQ
What was Opko Health Inc’s price range in the past 12 months?
Opko Health Inc lowest stock price was $0.86 and its highest was $1.76 in the past 12 months.
What is Opko Health Inc’s market cap?
Opko Health Inc’s market cap is $1.12B.
When is Opko Health Inc’s upcoming earnings report date?
Opko Health Inc’s upcoming earnings report date is Feb 27, 2025 which is in 8 days.
How were Opko Health Inc’s earnings last quarter?
Opko Health Inc released its earnings results on Nov 07, 2024. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of -$0.093 by $0.123.
Is Opko Health Inc overvalued?
According to Wall Street analysts Opko Health Inc’s price is currently Undervalued.
Does Opko Health Inc pay dividends?
Opko Health Inc does not currently pay dividends.
What is Opko Health Inc’s EPS estimate?
Opko Health Inc’s EPS estimate is -0.09.
How many shares outstanding does Opko Health Inc have?
Opko Health Inc has 682,483,030 shares outstanding.
What happened to Opko Health Inc’s price movement after its last earnings report?
Opko Health Inc reported an EPS of $0.03 in its last earnings report, beating expectations of -$0.093. Following the earnings report the stock price went up 4.828%.
Which hedge fund is a major shareholder of Opko Health Inc?
Currently, no hedge funds are holding shares in OPK
---
Opko Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (74.42% Upside)
$3.00 (74.42% Upside)
Blogger Sentiment
Bullish
OPK Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $2.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 8.0%
Last 30 Days ▲ 8.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
59.22%
12-Months-Change
Fundamentals
Return on Equity
-9.39%
Trailing 12-Months
Asset Growth
9.70%
Trailing 12-Months
Company Description
Opko Health Inc
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
---
OPK Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment, driven by strategic asset sales, strong growth in key diagnostics areas, and significant financial improvements. Despite some revenue declines in specific segments, the company's overall financial health and strategic partnerships indicate a strong position moving forward.Read More>---
OPK Stock 12 Month Forecast
Average Price Target
$3.00
▲(74.42% Upside)
Technical Analysis
Best Analysts Covering OPK
1 Year
1 Year Success Rate
17/38 ratings generated profit
1 Year Average Return
+11.38%
reiterated a buy rating 3 months ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 44.74% of your transactions generating a profit, with an average return of +11.38% per trade.
---